Frontiers in Neuroscience | Neuropharmacology

Original Research

Published on 05 Nov 2015

Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1

in Neuropharmacology

Maria G. Morgese
Marilena Colaianna
Emanuela Mhillaj
Margherita Zotti
Stefania Schiavone
Palma D'Antonio
Andrew Harkin
Valentina Gigliucci
Patrizia Campolongo
Viviana Trezza

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00428

5,676 views
29 citations

Original Research

Published on 05 Nov 2015

Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats

in Neuropharmacology

Shima Momeni
Lova Segerström
Erika Roman

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00424

6,793 views
43 citations

Review

Published on 05 Nov 2015

Glutamatergic transmission in drug reward: implications for drug addiction

in Neuropharmacology

Manoranjan S. D'Souza

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00404

42,715 views
132 citations

Review

Published on 05 Nov 2015

Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation

in Neuropharmacology

Laura G. Rosen
Ninglei Sun
Walter Rushlow
Steven R. Laviolette

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00399

10,990 views
33 citations

Review

Published on 21 Oct 2015

The role of inflammation in schizophrenia

in Neuropharmacology

Norbert Müller
Elif Weidinger
Bianka Leitner
Markus J. Schwarz

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00372

62,400 views
433 citations

Opinion

Published on 29 Sep 2015

Reward processing and drug addiction: does sex matter?

in Neuropharmacology

Liana Fattore

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00329

8,747 views
18 citations

Review

Published on 23 Sep 2015

An animal model of differential genetic risk for methamphetamine intake

in Neuropharmacology

Tamara Phillips
Shkelzen Shabani

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00327

8,350 views
22 citations

Original Research

Published on 23 Sep 2015

Enhanced functional connectivity involving the ventromedial hypothalamus following methamphetamine exposure

in Neuropharmacology

Damian Gabriel Zuloaga
Ovidiu Iancu
Sydney Weber
Desiree Etzel
Tessa Marzulla
Blair Stewart
Charles N. Allen
Jacob Raber

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00326

5,409 views
8 citations

Original Research

Published on 17 Sep 2015

Methylenedioxypyrovalerone (MDPV) mimics cocaine in its physiological and behavioral effects but induces distinct changes in NAc glucose

in Neuropharmacology

Ken Taro Wakabayashi
Suelynn E Ren
Eugene A Kiyatkin

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00324

65,908 views
17 citations

Review

Published on 03 Sep 2015

Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management

in Neuropharmacology

Antonio Ventriglio
Alessandro Gentile
Eleonora Stella
Antonello Bellomo

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00297

16,063 views
98 citations

Review

Published on 26 Aug 2015

Effects of anabolic-androgens on brain reward function

in Neuropharmacology

Emanuela Mhillaj
Maria Grazia Morgese
Paolo Tucci
Maria Bove
Stefania Schiavone
Luigia Trabace

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00295

61,820 views
42 citations

Review

Published on 10 Aug 2015

A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)'s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression

in Neuropharmacology

Yan Li
Alan L Pehrson
Jessica Ann Waller
Elena Dale
Connie Sanchez
Maria Gulinello

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00279

15,081 views
79 citations

Mini Review

Published on 29 Jul 2015

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes

in Neuropharmacology

Luca Steardo
Maria Rosanna Bronzuoli
Aniello Iacomino
Giuseppe Esposito
Luca Steardo
Caterina Scuderi

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00259

11,254 views
71 citations

Mini Review

Published on 21 Jul 2015

Antidepressant mechanism of ketamine: perspective from preclinical studies

in Neuropharmacology

Lisa Scheuing
Chi-Tso Chiu
Hsiao-Mei Liao
De-Maw Chuang

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00249

25,591 views
55 citations

Review

Published on 03 Jul 2015

Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity

in Neuropharmacology

Nathalie Castanon
Giamal Luheshi
Sophie Laye

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00229

26,793 views
163 citations

Review

Published on 03 Jul 2015

Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin

in Neuropharmacology

Theoharis Constantin Theoharides
Julia M Stewart
Erifili Hatziagelaki

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00225

177,803 views
141 citations

Review

Published on 18 Jun 2015

The role of maternal obesity in the risk of neuropsychiatric disorders

in Neuropharmacology

Heidi Michelle Rivera
Kelly J Christiansen
Elinor L Sullivan

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00194

36,335 views
267 citations

Original Research

Published on 17 Jun 2015

Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats

in Neuropharmacology

Mohd U. Ilmie
Hasnan Jaafar
Sharif M. Mansor
Jafri M. Abdullah

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00189

11,469 views
37 citations

Review

Published on 16 Jun 2015

Amylin at the interface between metabolic and neurodegenerative disorders

in Neuropharmacology

Thomas A. Lutz
Urs Meyer

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00216

20,826 views
93 citations

Review

Published on 16 Jun 2015

Aberrant insulin signaling in Alzheimer's disease: current knowledge

in Neuropharmacology

Gaurav Bedse
Fabio Di Domenico
Gaetano Serviddio
Tommaso Cassano

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00204

31,440 views
265 citations

Original Research

Published on 16 Jun 2015

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

in Neuropharmacology

Amanda Tivnan
Zaitun Zakaria
Caitrín O'Leary
Donat Kögel
Jenny L. Pokorny
Jann N. Sarkaria
Jochen H. M. Prehn

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00218

15,377 views
119 citations

Mini Review

Published on 09 Jun 2015

Therapeutic potential of mGluR5 targeting in Alzheimer's disease

in Neuropharmacology

Anil Kumar
Dinesh K. Dhull
Pooja S. Mishra

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00215

16,159 views
81 citations

Original Research

Published on 08 Jun 2015

Regulation of hypothalamic neuropeptides gene expression in diet induced obesity resistant rats: possible targets for obesity prediction?

in Neuropharmacology

Carlo Cifani
Maria V. Micioni Di Bonaventura
Mariangela Pucci
Maria E. Giusepponi
Adele Romano
Andrea Di Francesco
Mauro Maccarrone
Claudio D'Addario

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00187

18,752 views
65 citations

Review

Published on 03 Jun 2015

Immune aging, dysmetabolism, and inflammation in neurological diseases

in Neuropharmacology

Michela Deleidi
Madeline Jäggle
Graziella Rubino

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00172

29,446 views
255 citations

1,063 articles

articles

Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1

Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats

Glutamatergic transmission in drug reward: implications for drug addiction

Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation

The role of inflammation in schizophrenia

Reward processing and drug addiction: does sex matter?

An animal model of differential genetic risk for methamphetamine intake

Enhanced functional connectivity involving the ventromedial hypothalamus following methamphetamine exposure

Methylenedioxypyrovalerone (MDPV) mimics cocaine in its physiological and behavioral effects but induces distinct changes in NAc glucose

Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management

Effects of anabolic-androgens on brain reward function

A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)'s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes

Antidepressant mechanism of ketamine: perspective from preclinical studies

Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity

Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin

The role of maternal obesity in the risk of neuropsychiatric disorders

Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats

Amylin at the interface between metabolic and neurodegenerative disorders

Aberrant insulin signaling in Alzheimer's disease: current knowledge

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

Therapeutic potential of mGluR5 targeting in Alzheimer's disease

Regulation of hypothalamic neuropeptides gene expression in diet induced obesity resistant rats: possible targets for obesity prediction?

Immune aging, dysmetabolism, and inflammation in neurological diseases